tol-463
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2013 (NCT01812889)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- tol-463
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03930745 | Phase 2 | Jul 1, 2019 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT02866227 | Phase 2 | Jul 15, 2016 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT01812889 | Phase 1 | Apr 1, 2013 | National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 3 | 3 | 2 | 2013 |
1 organizations
Page 1 / 1